Obesity-related cardiometabolic risk factors associate with COVID-19 severity and outcomes. Epicardial adipose tissue (EAT) is associated with cardiometabolic disturbances, is a source of proinflammatory cytokines and a marker of visceral adiposity. We investigated the relation between EAT characteristics and outcomes in COVID-19 patients.
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study
Conte, CaterinaPrimo
;Esposito, AntonioSecondo
;De Lorenzo, Rebecca;Di Filippo, Luigi;Palmisano, Anna;Vignale, Davide;Leone, Riccardo;Nicoletti, Valeria;Secchi, Antonio;Bosi, Emanuele;Castagna, Antonella;Landoni, Giovanni;Zangrillo, Alberto;De Cobelli, Francesco;Ciceri, Fabio;Camici, PaoloPenultimo
;Rovere-Querini, PatriziaUltimo
2021-01-01
Abstract
Obesity-related cardiometabolic risk factors associate with COVID-19 severity and outcomes. Epicardial adipose tissue (EAT) is associated with cardiometabolic disturbances, is a source of proinflammatory cytokines and a marker of visceral adiposity. We investigated the relation between EAT characteristics and outcomes in COVID-19 patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
